Health Awareness
Liver Health Q1 2022
-
Liver disease: getting more from your blood test
Rates of liver disease are increasing across the United Kingdom. It is a rapidly rising cause of death in those under the age of 65. Since 1970, there has been between a 400-500% increase in the mortality rates for liver disease. This is in a stark contrast to most other diseases where the mortality rates...
-
Progress is being made in new treatments for liver cancer
Treatment of cancer has recognised a true revolution in the past two decades. Those who treat liver tumours could not hope for a better time to shake up clinical practice. For way too long and despite incessant efforts from clinicians, patients, universities, charities and industry – liver tumours have remained neglected orphans from the transformative...
-
Greater awareness is needed of NAFLD
Samantha shares her experiences of her mother suffering with non-alcohol related fatty liver disease (NAFLD). Greater awareness of condition could help earlier diagnosis and save lives. My mum was diagnosed with NAFLD on 19th April 2018 and sadly passed away just four days later. At her inquest, the coroner cited missed opportunities for diagnosis and treatment....
-
How to stop the NAFLD domino effect
In recent years, non-alcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease. Based on the official studies, NAFLD affects one in four adults and one in 10 children/adolescents in Europe1. The prevalence and incidence of the condition are expected to increase worldwide as the global obesity epidemic spreads and...
-
s Sponsored
Regenerative nanotherapy to treat NAFLD
Non-alcoholic fatty liver disease (NAFLD) is a major chronic liver disease affecting over 24% of the world’s adult population. While NAFLD/steatosis is benign and can be reversed with lifestyle and diet modifications, over 30% of the NAFLD population can progress to a more advanced stage known as non-alcoholic steatohepatitis (NASH), characterised by inflammation, fibrosis and...
-
s Sponsored
Stepping up care standards for patients with a rare liver disease
Treatment for patients with a rare and chronic liver condition could be significantly improved following a nationwide audit of NHS centres. Primary biliary cholangitis (PBC) is a rare liver disease that occurs in fewer than one in 2,000 people. It is a leading indication for liver transplantation in the UK. Hepatologists from almost all NHS...
-
Improving detection and management of liver disease
In the last 50 years there have been enormous improvements in healthcare, yet the number of people dying from liver disease has increased by 400%. The number of people dying from liver disease is a stark contrast to other major killer diseases, such as heart disease and cancer, in which the number of deaths have either...
-
s Sponsored
Global Liver Institute launches a new global public health initiative in liver health
Despite affecting more than half a billion people, liver conditions continue to be misunderstood and stigmatised, resulting in under-diagnosis, under-treatment and poor outcomes. A new initiative to raise the profile of liver disease as a major public health issue is being launched globally. Donna Cryer, CEO of Global Liver Institute (GLI), the non-profit organisation representing...
-
Liver cancer is an all-out battle
Over the past 20 years, there has been a 70% increase in liver cancer-related mortality in Europe.1 From 1997 to 2016, incidence and deaths from hepatocellular carcinoma (HCC) have tripled in England.2 Unfortunately, liver cancer is usually asymptomatic. When discovered, it could be too late. At an advanced stage, options are limited and connected to...
